Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 21;11(2):132.
doi: 10.3390/pathogens11020132.

Epstein-Barr Virus Infection in Lung Cancer: Insights and Perspectives

Affiliations
Review

Epstein-Barr Virus Infection in Lung Cancer: Insights and Perspectives

Julio C Osorio et al. Pathogens. .

Abstract

Lung cancer (LC) is the leading cause of cancer death worldwide. Tobacco smoke is the most frequent risk factor etiologically associated with LC, although exposures to other environmental factors such as arsenic, radon or asbestos are also involved. Additionally, the involvement of some viral infections such as high-risk human papillomaviruses (HR-HPVs), Merkel cell polyomavirus (MCPyV), Jaagsiekte Sheep Retrovirus (JSRV), John Cunningham Virus (JCV), and Epstein-Barr virus (EBV) has been suggested in LC, though an etiological relationship has not yet been established. EBV is a ubiquitous gamma herpesvirus causing persistent infections and some lymphoid and epithelial tumors. Since EBV is heterogeneously detected in LCs from different parts of the world, in this review we address the epidemiological and experimental evidence of a potential role of EBV. Considering this evidence, we propose mechanisms potentially involved in EBV-associated lung carcinogenesis. Additional studies are warranted to dissect the role of EBV in this very frequent malignancy.

Keywords: Epstein–Barr virus; cancer; lung.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Epstein–Barr virus genome organization. (A) EBV lineal genome. (B) EBV circular genome representation.
Figure 2
Figure 2
EBV proteins in epithelial tumors and their functions in cancer progression. This model suggests initial damage that can be caused by environmental pollutants (xenobiotics). Next, the epithelial injury allows the EBV latency establishment with the subsequent EBV protein expression. Finally, the EBV protein expression allows the activation of different cell signaling pathways such as Wnt/β-catenin, NF-κB, JNK, JAK/STAT, EGFR/MAPK, and PI3K/AKT.
Figure 3
Figure 3
CD21 (CR2) transcript expression in LC (TCGA, n = 1325) according to sample type and histological classification of tumors (***: p < 0.001 for both; Welch’s t-test). The expression of CD21 was increased 1.8-fold in malignant tumors (1323 primary tumors and two recurrences) and increased 1.3-fold in lung AdC compared to normal tissue and lung SQC. Raw data were extracted from University of California, Santa Cruz (ena.ucsc.edu). UCSC Xena functional genomics explorer (https://xenabrowser.net) [200].
Figure 4
Figure 4
Hypothetical mechanism of interaction between cigarette smoke components or environmental contaminants with EBV in lung epithelial cells. This interaction involves local immunosuppression facilitating EBV infection, latency establishment, and latent/lytic switch activation.

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Chen Z., Fillmore C.M., Hammerman P.S., Kim C.F., Wong K.-K. Non-small-cell lung cancers: A heterogeneous set of diseases. Nat. Cancer. 2014;14:535–546. doi: 10.1038/nrc3775. - DOI - PMC - PubMed
    1. Semenova E.A., Nagel R., Berns A. Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes Dev. 2015;29:1447–1462. doi: 10.1101/gad.263145.115. - DOI - PMC - PubMed
    1. Oser M.G., Niederst M.J., Sequist L.V., Engelman J.A. Transformation from non-small-cell lung cancer to small-cell lung cancer: Molecular drivers and cells of origin. Lancet Oncol. 2015;16:e165–e172. doi: 10.1016/S1470-2045(14)71180-5. - DOI - PMC - PubMed
    1. Reis-Filho J.S., Simpson P.T., Martins A., Preto A., Gärtner F., Schmitt F.C., Archiv V. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch. 2003;443:122–132. - PubMed

LinkOut - more resources